Patent ID: 6350772
Filing Date: 2002-02-26
Classification: A61K,A61P,C07D

Abstract:
A method for photochemotherapeutically treating systemic lupus erythematosus in a patient in need thereof, which comprises:a) administering orally or parenterally to a patient being treated for systemic lupus erythematosus a compound selected from the group consisting of mono-L-aspartyl chlorin e6, mono-L-glutamyl chlorin e6, or pharmacologically acceptable salts thereof, at a dosage of about 0.2 to about 10 mg per day: b) irradiating percutaneously the blood stream containing the administered compound within the blood vessels of the entire body, or a part or parts of the body of the patient, or irradiating an extracorporeally circulated blood stream containing the administered compound, with a laser light of a wavelength of about 620 to about 760 nm at a radiation intensity of about 10 to about 100 mW/cm2, thereby subjecting said compound to exposure with the irradiating laser light whereby said compound is excited photochemically.